Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-04-28

Clinical Trial Update: The Effect of Omega-3 Supplementation on Nerve Structure and Function in Type 1 Diabetes [Phase 2]

View source ↗

Summary

Phase 2 trial update on omega-3 fatty acid supplementation and its effects on nerve structure and function in Type 1 diabetes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Omega-3 fatty acids (omega-3 fatty acids)

Snippet

Sponsor: Eduardo Ng | Conditions: Type 1 Diabetes | Phase 2 | Status: COMPLETED